Cantor Fitzgerald Starts TherapeuticsMD (TXMD) at Overweight
Tweet
Share
E-mail
Get Alerts TXMD Hot Sheet
Price: $2.05 -3.76%
Rating Summary:
10 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
10 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
Cantor Fitzgerald initiated coverage on TherapeuticsMD (NYSE: TXMD) with an Overweight rating and a price target of $34.00.
For an analyst ratings summary and ratings history on TherapeuticsMD click here. For more ratings news on TherapeuticsMD click here.
Shares of TherapeuticsMD closed at $5.54 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kotak Starts Dhoot Transmission (DHOOTTRA:IN) at Sell (4)
- JPMorgan Assumes Yonyou Network Technology Co Ltd (600588:CH) at Underweight
- StoneX Starts Viking Holdings (VIK) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cantor FitzgeraldSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
